Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Network Type I Analysis

Type 1 network in which we propagated the absolute log regulation ratio abs(log(r/g)). We used the filtered lowest boundary of the confidence interval for the microarray measurement based and used the high confidence interaction map. Because type-I networks tend to favour highly connected proteins we tested a normalisation scheme in which we would run the network once with real values (the measured column) and once with simulated values where each measured point is set to 1 instead of the actual signal (the expected column). Afterwards we divided the measured value by the expected value. This normalisation scheme works to a certain extend but will lead to a variance that is directly related to the connectivity of each protein. In the end we dropped the use of Type-I networks due to the many technical problems they pose.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Gene Rank description measured expected final Hugo
Results: HTML CSV LaTeX
Showing element 651 to 700 of 3206 in total

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
measured\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
expected\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
final\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
651\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DAZ ASSOCIATED PROTEIN 1 ISOFORM B; DELETED IN AZOOSPERMIA ASSOCIATED PROTEIN 1. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0774957\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.289339\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.267837035\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
DAZAP1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
652\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.170567\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.63684\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.267833365\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ZMIZ2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
653\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
AUTOPHAGY PROTEIN 5-LIKE (APG5-LIKE) (APOPTOSIS-SPECIFIC PROTEIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.40611\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.51635\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.267820754\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ATG5\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
654\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CYSTEINE-RICH PROTEIN 1 (CYSTEINE-RICH INTESTINAL PROTEIN) (CRIP) (CYSTEINE-RICH HEART PROTEIN) (HCRHP). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.113218\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.423045\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.267626375\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
655\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EUKARYOTIC TRANSLATION INITIATION FACTOR 4E (EIF-4E) (EIF4E) (MRNA CAP-BINDING PROTEIN) (EIF-4F 25 KDA SUBUNIT). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.173445\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.648176\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.267589358\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
EIF4E\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
656\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
BAI1-ASSOCIATED PROTEIN 3; BAI-ASSOCIATED PROTEIN 3. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0241104\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.0901025\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.26758858\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
BAIAP3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
657\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
STEP II SPLICING FACTOR SLU7. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0404532\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.151367\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.267252439\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SLU7\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
658\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
U2 SMALL NUCLEAR RIBONUCLEOPROTEIN AUXILIARY FACTOR 35 KDA SUBUNIT RELATED-PROTEIN 1. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.20255\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.757899\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.267251969\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
659\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SECRETED MODULAR CALCIUM-BINDING PROTEIN 1. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0285187\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.106766\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.267114063\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
660\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SECRETED MODULAR CALCIUM-BINDING PROTEIN 2; SMOOTH MUSCLE ASSOCIATED PROTEIN 2. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.035822\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.134108\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.267113073\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SMOC2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
661\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PREFOLDIN SUBUNIT 1. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.128438\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.480838\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.267112832\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PFDN1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
662\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CHOLINE DEHYDROGENASE. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.100197\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.375112\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.267112222\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CHDH\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
663\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HOMEOBOX PROTEIN SIX2 (SINE OCULIS HOMEOBOX HOMOLOG 2). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.516908\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.93534\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.267088987\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SIX2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
664\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
BRCA1-ASSOCIATED RING DOMAIN PROTEIN 1 (BARD-1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.122728\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.45954\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.267067067\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
BARD1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
665\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PROLIFERATION-ASSOCIATED PROTEIN 2G4 (CELL CYCLE PROTEIN P38-2G4 HOMOLOG) (HG4-1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.083217\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.311645\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.26702498\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PA2G4\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
666\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HOMEOBOX PROTEIN SIX1 (SINE OCULIS HOMEOBOX HOMOLOG 1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.617064\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.31135\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.266971251\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SIX1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
667\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SQV-7-LIKE PROTEIN (FRAGMENT). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.104453\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.391317\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.266926814\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SLC35D2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
668\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FIDGETIN-LIKE 1. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.431627\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.61735\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.266872971\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
FIGNL1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
669\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.11907\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.44632\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.266781681\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
RSRC2\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
670\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
0.167849\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.629342\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.266705543\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
USP30\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
671\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
INTERLEUKIN ENHANCER-BINDING FACTOR 1 (CELLULAR TRANSCRIPTION FACTOR ILF-1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0872849\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.327271\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.266705269\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
FOXK2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
672\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0436424\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.163636\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.266704148\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
673\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
0.105333\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.394979\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.266680001\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SFT2D3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
674\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KINESIN FAMILY MEMBER C3. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0861152\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.323402\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.26627912\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
KIFC3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
675\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
P47 PROTEIN ISOFORM A. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0978055\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.367477\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.266154072\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
NSFL1C\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
676\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"TRYPTOPHAN 2,3-DIOXYGENASE (EC 1.13.11.11) (TRYPTOPHAN PYRROLASE) (TRYPTOPHANASE) (TRYPTOPHAN OXYGENASE) (TRYPTAMIN 2,3-DIOXYGENASE) (TRPO). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.157338\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.591312\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.26608288\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
TDO2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
677\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SERINE/THREONINE-PROTEIN KINASE PLK (EC 2.7.1.-) (PLK-1) (SERINE- THREONINE PROTEIN KINASE 13) (STPK13). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.170317\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.640229\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.266025125\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PLK1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
678\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TUBULIN TYROSINE LIGASE-LIKE PROTEIN HOTTL (HQP0207). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.544593\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.04792\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.265924938\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
BRPF1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
679\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MITOGEN-ACTIVATED PROTEIN KINASE 3 (EC 2.7.1.37) (EXTRACELLULAR SIGNAL-REGULATED KINASE 1) (ERK-1) (INSULIN-STIMULATED MAP2 KINASE) (MAP KINASE 1) (MAPK 1) (P44-ERK1) (ERT2) (P44-MAPK) (MICROTUBULE- ASSOCIATED PROTEIN-2 KINASE). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1.11399\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4.19348\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.265648101\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
MAPK3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
680\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 5 (EC 2.7.1.-) (MAPK/ERK KINASE KINASE 5) (MEK KINASE 5) (MEKK 5) (APOPTOSIS SIGNAL- REGULATING KINASE 1) (ASK-1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.166963\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.628521\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.265644266\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
681\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE TYPE II ALPHA CHAIN (EC 2.7.1.123) (CAM-KINASE II ALPHA CHAIN) (CAM KINASE II ALPHA SUBUNIT) (CAMK-II ALPHA SUBUNIT). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.141368\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.532171\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.265643938\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CAMK2A\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
682\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE TYPE II BETA CHAIN (EC 2.7.1.123) (CAM-KINASE II BETA CHAIN) (CAM KINASE II BETA SUBUNIT) (CAMK-II BETA SUBUNIT). \vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.159505\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.600447\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.265643762\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
CAMK2B\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
683\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE TYPE II DELTA CHAIN (EC 2.7.1.123) (CAM-KINASE II DELTA CHAIN) (CAM KINASE II DELTA SUBUNIT) (CAMK-II DELTA SUBUNIT). \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
CAMK2D\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
684\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RIBOSOMAL PROTEIN S6 KINASE ALPHA 3 (EC 2.7.1.37) (S6K-ALPHA 3) (90 KDA RIBOSOMAL PROTEIN S6 KINASE 3) (P90-RSK 3) (RIBOSOMAL S6 KINASE 2) (RSK-2) (PP90RSK2) (INSULIN-STIMULATED PROTEIN KINASE 1) (ISPK-1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0708493\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.266708\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.2656437\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
RPS6KA3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
685\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HISTIDINE AMMONIA-LYASE (EC 4.3.1.3) (HISTIDASE). \vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.0814182\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.306494\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.265643699\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
HAL\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
686\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RIBOSOMAL PROTEIN S6 KINASE ALPHA 1 (EC 2.7.1.37) (S6K-ALPHA 1) (90 KDA RIBOSOMAL PROTEIN S6 KINASE 1) (P90-RSK 1) (RIBOSOMAL S6 KINASE 1) (RSK-1) (PP90RSK1). \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
RPS6KA1\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
687\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
SIPA1L2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
688\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SIGNAL-INDUCED PROLIFERATION-ASSOCIATED 1-LIKE 1. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0671866\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.25292\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.265643682\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
689\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE TYPE II GAMMA CHAIN (EC 2.7.1.123) (CAM-KINASE II GAMMA CHAIN) (CAM KINASE II GAMMA SUBUNIT) (CAMK-II GAMMA SUBUNIT) (FRAGMENT). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.139426\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.524861\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.265643666\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CAMK2G\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
690\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RIBOSOMAL PROTEIN S6 KINASE ALPHA 6 (EC 2.7.1.37) (S6K-ALPHA 6) (90 KDA RIBOSOMAL PROTEIN S6 KINASE 6) (P90-RSK 6) (RIBOSOMAL S6 KINASE 4) (RSK-4) (PP90RSK4). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0671204\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.252671\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.265643465\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
RPS6KA6\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
691\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RIBOSOMAL PROTEIN S6 KINASE ALPHA 2 (EC 2.7.1.37) (S6K-ALPHA 2) (90 KDA RIBOSOMAL PROTEIN S6 KINASE 2) (P90-RSK 2) (RIBOSOMAL S6 KINASE 3) (RSK-3) (PP90RSK3). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0698564\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.262971\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.26564298\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
RPS6KA2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
692\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0644285\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.242538\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.26564291\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SIPA1L3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
693\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"GLUTARYL-COA DEHYDROGENASE, MITOCHONDRIAL PRECURSOR (EC 1.3.99.7) (GCD). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.125547\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.472616\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.265642721\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
GCDH\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
694\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"ATP-BINDING CASSETTE, SUB-FAMILY D, MEMBER 3 (70 KDA PEROXISOMAL MEMBRANE PROTEIN) (PMP70). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0441291\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.166122\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.26564272\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ABCD3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
695\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 6 (EC 2.7.1.-). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.126275\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.475357\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.265642454\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
MAP3K6\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
696\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MITOGEN-ACTIVATED PROTEIN KINASE 1 (EC 2.7.1.37) (EXTRACELLULAR SIGNAL-REGULATED KINASE 2) (ERK-2) (MITOGEN-ACTIVATED PROTEIN KINASE 2) (MAP KINASE 2) (MAPK 2) (P42-MAPK) (ERT1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1.33288\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5.01763\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.265639356\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
MAPK1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
697\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EPIDERMAL GROWTH FACTOR RECEPTOR PATHWAY SUBSTRATE 8-LIKE PROTEIN 2; EPS8-RELATED PROTEIN 2; EPIDERMAL GROWTH FACTOR RECEPTOR PATHWAY SUBSTRATE 8-RELATED PROTEIN 2. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.128497\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.483922\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.265532462\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
EPS8L2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
698\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
15 KDA SELENOPROTEIN PRECURSOR. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0424293\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.159817\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.265486775\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
699\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.160096\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.603029\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.265486403\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
USP47\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
700\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EPIDERMAL GROWTH FACTOR RECEPTOR KINASE SUBSTRATE EPS8. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.101882\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.383993\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.265322545\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
EPS8\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the bloody hugo identifier as demanded by the BMC Bioinformatics idiots
- http://analysis.yellowcouch.org/